UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 5
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
John B. Zaepfel
1401 Walnut Street, Suite 540
Boulder, Colorado 80302
2. Issuer Name and Ticker or Trading Symbol
Pro-Dex, Inc./ PDEX
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. June/1998
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
(X) Director ( ) 10% Owner ( ) Officer (give title below)
( ) Other (specify below)
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
________________________________________________________________________________
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
________________________________________________________________________________
1.Title of Security |2.Trans-|3.Trans-|4.Securities Acquired (A) |5.Amount of
(Instruction 3) |action |action |or Disposed of (D) |Securities
|Date |Code |(Instr. 3, 4, and 5) |Beneficially
| |(Instr. | |Owned at end
|(Month/ | 8) | |of Issuer's
| Day/ | |___________________________|Fiscal Year
| Year) | | Amount |(A)or(D)| Price |(Instr. 3&4)
_____________________|________|________|________|________|_________|____________
| | | | | | |
_____________________|________|____|___|________|________|_________|____________
| | | | | | |
_____________________|________|____|___|________|________|_________|____________
____________________________________________________________
6.Ownership Form: |7.Nature of
Direct (D) or | Indirect Beneficial
Indirect (I) | Ownership
(Instr. 4) | (Instr. 4)
____________________|_______________________________________
|
____________________|_______________________________________
|
____________________|_______________________________________
________________________________________________________________________________
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securites)
_______________________________________________________________________________
1.Title of Derivative|2.Con- |3.Trans-|4.Trans-|5.Number of|6.Date |7.Title
Security (Instr. 3) |version |action |action |Derivative |Exer- |and
|or Exer-|Date |Code |Securities |cisable |amount of
|cise |(Month/ |(Instr. |Acquired(A)|and Ex- |Under-
|Price | Day/ | 8) |or Disposed|piration |lying
|of De- | Year) | |of (D) |Date |Secur-
|rivative| | |(Instr. 3, |(Month/ |ities
|Security| | | 4, and 5) | Day/ |(Instr.
| | | |___________| Year) |4)
| | | | (A) | (D) | |
_____________________|________|________|________|_____|_____|_________|_________
Option to Acquire | | | | | |
Pro-Dex,Inc. | 2.44 |08/28/96| A | |08/28/96-| Common/
Common Stock* | | | | |08/28/06 | 20,000
_____________________|________|________|________|___________|_________|_________
Option to Acquire | | | | | |
Pro-Dex, Inc. | 2.90 |08/28/97| A | |08/28/97-| Common/
Common Stock* | | | | |08/28/07 | 15,000
_____________________|________|________|________|___________|_________|_________
__________________________________________________________
8.Price of |9.Number of |10.Ownership Form |11.Nature of
Derivative |Derivative |of Derivative |Indirect
Security |Securities, |Security: |Beneficial
(Instr. 5) |Beneficially |Direct (D) or |Ownership
|Owned at End |Indirect (I) |(Instr. 4)
|of Year |(Instr. 4) |
|(Instr. 4) | |
___________|_____________|__________________|_____________
| | D |
___________|_____________|__________________|_____________
| 35,000 | D |
___________|_____________|__________________|_____________
Explanation of Responses:
* The options will expire, if not exercised, 90 days after the Optionee
ceases to act as a Director.
SIGNATURE OR REPORTING PERSON
/s/ John B. Zaepfel
DATE
August 7, 1998
</sec-DOCUMENT>
